Office of Research & Development |
|
Project Number: | I01CX002349-01A2 |
Title: | A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer |
Principal Investigator: | David H Wang |
Location: | Dallas, TX |
Congressional District Code: | 30 |
Research Service: | Clinical Science R&D |
Project Period: | April 2023 - March 2028 |
FY 2025 Funding Amount: | $583,004 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |